Properties:
| Related Categories |
Additional Standards,
Analytical Standards,
Analytical/Chromatography,
Antipsychotics,
Antipsychotics Standards,
|
|
grade
|
certified reference material
|
|
InChI Key
|
GMDCDXMAFMEDAG-BTJKTKAUSA-N
|
|
feature
|
SNAP-N-SPIKE®, SNAP-N-SHOOT®
|
|
packaging
|
ampule of 1 mL
|
|
concentration
|
1.0 mg/mL in methanol (as free base)
|
|
format
|
single component solution
|
|
storage temp.
|
−20°C
|
Description:
General description
Asenapine is a new atypical antipsychotic developed for the treatment of schizophrenia and acute mania associated with bipolar disorder. The drug is marketed under the trade names Saphris® and Sycrest. This certified solution standard is suitable for LC/MS or GC/MS applications in clinical toxicology, forensic testing, or pharmaceutical research.
Legal Information
Saphris is a registered trademark of Merck Sharp & Dohme B.V.
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Cerilliant Corporation
Safety:
Hazard statements
H225-H301 + H311 + H331-H370
Precautionary statements
P210-P260-P280-P301 + P310-P311
RIDADR
UN1230 - class 3 - PG 2 - Methanol, solution